Avita Medical | 1811094D - 流动负债



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 152.75M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


流动负债 更改 日
Accuray USD 199.44M 4.83M 2025-12
Celltrion KRW 283.62B 3.72T 2025-12
Clinuvel Pharmaceuticals AUD 17.85M 9.36M 2025-12
Cochlear AUD 558.9M 43.4M 2025-12
CSL USD 4.61B 207M 2025-12
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 38.28M 7.55M 2026-03
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Mayne Pharma AUD 313.94M 18.28M 2024-06
Medical Developments International AUD 5.56M 2.26M 2025-12
Nanosonics AUD 36.59M 3.2M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 94.05M 32.11M 2025-12
Ovoca Bio EUR 186K 2.26M 2025-06
Pacific Edge NZD 6.82M 400K 2026-06
Paradigm Biopharmaceuticals AUD 16.6M 13.37M 2025-12
Pharma Mar EUR 89.23M 4.65M 2026-03
Polynovo AUD 22.81M 5.07M 2025-12
PYC Therapeutics AUD 11.01M 1.31M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Ramsay Health Care AUD 3.95B 514.2M 2025-12
ResMed USD 1.25B 7.39M 2025-12
Sartorius EUR 2.11B 145.8M 2026-03
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Telix Pharmaceuticals AUD 231.62M 66.96M 2025-12
Tilray USD 259.32M 8.32M 2025-09
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03